Glastad Invest

Total investments

1

Average round size

7M

Portfolio companies

1

Rounds per year

0.01

Areas of investment
BiotechnologyHealth CareClinical Trials

Summary

In 1910 was created Glastad Invest, which is appeared as VC. The main department of described VC is located in the Farsund. The company was established in Europe in Norway.

The fund is generally included in less than 2 deals every year. The important activity for fund was in 2007. The usual things for fund are deals in the range of 5 - 10 millions dollars.

The typical case for the fund is to invest in rounds with 5 participants. The meaningful sponsors for the fund in investment in the same round are Teknoinvest, Innovations Kapital, Gezina. In the next rounds fund is usually obtained by Teknoinvest, Investinor, Innovations Kapital.

Moreover, a startup needs to be at the age of 11-15 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Biotechnology, Health Care. Among the various public portfolio startups of the fund, we may underline SantoSolve For fund there is a match between the location of its establishment and the land of its numerous investments - Norway.

Show more

Investments analytics

Analytics

Total investments
1
Lead investments
0
Rounds per year
0.01
Investments by industry
  • Clinical Trials (1)
  • Biotechnology (1)
  • Health Care (1)
Investments by region
  • Norway (1)
Peak activity year
2007

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
27
Group Appearance index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.